EVO:NSD-Evotec SE ADR (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 4.93

Change

-0.24 (-4.64)%

Market Cap

USD 1.83B

Volume

0.14M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-23 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
NBIX Neurocrine Biosciences Inc

N/A

USD 13.58B
VTRS Viatris Inc

N/A

USD 12.47B
ITCI Intracellular Th

N/A

USD 7.22B
LNTH Lantheus Holdings Inc

N/A

USD 5.60B
ALKS Alkermes Plc

N/A

USD 4.15B
ALVO Alvotech

N/A

USD 3.93B
HCM HUTCHMED DRC

N/A

USD 3.17B
INDV Indivior PLC Ordinary Shares

N/A

USD 2.47B
DCPH Deciphera Pharmaceuticals LLC

N/A

USD 2.21B
AMPH Amphastar P

N/A

USD 1.98B

ETFs Containing EVO

EXV9:F iShares (DE) I - iShares .. 14.25 % 0.00 %

N/A

USD 0.08B
EXV9:XETRA iShares (DE) I - iShares .. 14.25 % 0.00 %

N/A

USD 0.10B
BETS:XETRA 6.59 % 0.00 %

N/A

N/A
ODDS Pacer BlueStar Digital En.. 6.56 % 0.00 %

N/A

USD 0.88M
XSSX:LSE Xtrackers - Euro Stoxx 50.. 4.73 % 0.00 %

N/A

USD 0.05B
DXSP:F Xtrackers - Euro Stoxx 50.. 4.73 % 0.00 %

N/A

USD 0.05B
DXSP:XETRA Xtrackers - Euro Stoxx 50.. 4.73 % 0.00 %

N/A

USD 0.05B
XSDX:LSE Xtrackers ShortDAX Daily .. 3.88 % 0.00 %

N/A

USD 0.20B
DXSN:F Xtrackers - ShortDAX Dail.. 3.88 % 0.00 %

N/A

USD 0.20B
DXSN:XETRA Xtrackers - ShortDAX Dail.. 3.88 % 0.00 %

N/A

USD 0.21B
XSDX:SW Xtrackers ShortDAX Daily .. 3.88 % 0.00 %

N/A

USD 0.20B
EWD iShares MSCI Sweden ETF 3.48 % 0.53 %

N/A

USD 0.39B
BJK VanEck Gaming ETF 0.00 % 0.66 %

N/A

USD 0.04B
IESZ:LSE 0.00 % 0.00 %

N/A

N/A
OMXS:LSE iShares OMX Stockholm Cap.. 0.00 % 0.00 %

N/A

USD 4.49B
EL4C:F Deka STOXX Europe Strong .. 0.00 % 0.00 %

N/A

USD 0.26B
XDN0:F db x-trackers MSCI Nordic.. 0.00 % 0.00 %

N/A

USD 1.10B
EL4C:XETRA Deka STOXX Europe Strong .. 0.00 % 0.00 %

N/A

USD 0.29B
OM3X:XETRA iShares OMX Stockholm Cap.. 0.00 % 0.00 %

N/A

USD 1.31B
XDN0:XETRA db x-trackers MSCI Nordic.. 0.00 % 0.00 %

N/A

USD 1.03B
DXW:CA Dynamic Active Internatio.. 0.00 % 0.00 %

N/A

CAD 0.02B
BETZ Roundhill Sports Betting .. 0.00 % 0.00 %

N/A

USD 0.08B
XNZN:XETRA Xtrackers Nordic Net Zero.. 0.00 % 0.00 %

N/A

USD 0.18B
XDN0:SW Xtrackers MSCI Nordic UCI.. 0.00 % 0.00 %

N/A

USD 1.09B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -57.97% 12% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -57.97% 12% F 7% C-
Trailing 12 Months  
Capital Gain -54.56% 31% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -54.56% 31% F 17% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -10.66% 46% F 26% F
Dividend Return -10.66% 46% F 26% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 21.37% 91% A- 74% C
Risk Adjusted Return -49.90% 38% F 20% F
Market Capitalization 1.83B 87% B+ 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector